Bruce G. Haffty

Sep 4, 2024 | redjournal.org | Bruce G. Haffty |Livingston New Jersey

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes 1Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey 2RWJBarnabas Health, Livingston New Jersey 3Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey 4Division of Medical Oncology, Rutgers Cancer Institute of New Jersey...

Aug 26, 2024 | onclive.com | Bruce G. Haffty

Bruce G. Haffty, MD, MS, FACR, FASTRO, chair, Radiation Oncology, associate vice chancellor for Cancer Programs, Rutgers Cancer Institute of New Jersey, system director, Radiation Oncology, RWJ Barnabas Health, discusses the evolving considerations regarding the omission of regional nodal radiation therapy in patients with node-positive breast cancer who convert to node-negative status after neoadjuvant chemotherapy.

Nov 11, 2023 | onclive.com | Bruce G. Haffty

Bruce Haffty, MD, MS, chair, Radiation Oncology, associate vice chancellor for Cancer Programs, Rutgers Cancer Institute of New Jersey, system director, Radiation Oncology, RWJBarnabas Health, discusses the significance of technical and biological advancements in approaches to radiotherapy, and how they engendered the de-escalation of radiotherapy for select patients with breast cancer.

Oct 6, 2023 | onclive.com | Bruce G. Haffty

Bruce Haffty, MD, MS, chair, Radiation Oncology, associate vice chancellor for Cancer Programs, Rutgers Cancer Institute of New Jersey, system director, Radiation Oncology, RWJBarnabas Health, discusses the rationale for launching a clinical trial to assess the feasibility of preoperative radiation boost in patients with breast cancer. Patients with breast cancer who undergo a lumpectomy typically receive whole breast radiation therapy following the procedure, Haffty begins.

Oct 5, 2023 | onclive.com | Bruce G. Haffty

Bruce Haffty, MD, MS, chair, Radiation Oncology, associate vice chancellor, Cancer Programs, Rutgers Cancer Institute of New Jersey, system director, Radiation Oncology, RWJBarnabas Health, discusses the feasibility of utilizing preoperative radiation boost in patients with breast cancer based on initial results from a phase 2 trial (NCT04871516). The prospective trial was launched to assess the safety and efficacy of delivering radiation boost prior to breast-conserving surgery, Haffty begins.